Kimberly Murphy - 08 Aug 2023 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
CEO and President, Director
Signature
/s/ Mark A. Catchur, as Attorney-in-Fact for Kimberly Murphy
Issuer symbol
OGEN
Transactions as of
08 Aug 2023
Transactions value $
$0
Form type
4
Filing time
10 Aug 2023, 16:30:31 UTC
Previous filing
24 Jun 2022
Next filing
20 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGEN Common Stock Award $0 +25K $0.00 25K 08 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with serving as the Company President and Chief Executive Officer with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.